Filters: Author is Bruce, Robert Douglas [Clear All Filters]
"Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 47, no. 7 (2008): 952-61. Abstract
"Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial." Journal of acquired immune deficiency syndromes (1999) 50, no. 2 (2009): 176-81. Abstract
"Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir." Journal of acquired immune deficiency syndromes (1999) 54, no. 5 (2010): 511-4. Abstract
"Additional explanation for lack of pharmacodynamic interaction between atazanavir and buprenorphine reported by Vergara-Rodriquez et al." Journal of acquired immune deficiency syndromes (1999) 58, no. 4 (2011): e112; author reply e112-3.
"Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence." The American journal of drug and alcohol abuse 37, no. 1 (2011): 1-11. Abstract
"Implementation and Operational Research: Linkage to Care Among Methadone Clients Living With HIV in Dar es Salaam, Tanzania." Journal of acquired immune deficiency syndromes (1999) 69, no. 2 (2015): e43-8. Abstract
"The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2015). Abstract
